世界のグラム陰性菌感染症治療薬市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Gram-Negative Bacterial Infection Therapeutics Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4272 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、95ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、グラム陰性菌感染症治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経腸治療、非経口治療、局所治療）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・グラム陰性菌感染症治療薬の市場動向 ・企業の競争状況、市場シェア ・グラム陰性菌感染症治療薬の種類別市場規模と予測2016-2027（経腸治療、非経口治療、局所治療） ・グラム陰性菌感染症治療薬の用途別市場規模と予測2016-2027（病院、診療所、その他） ・グラム陰性菌感染症治療薬の北米市場規模2016-2027（アメリカ、カナダ） ・グラム陰性菌感染症治療薬の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・グラム陰性菌感染症治療薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・グラム陰性菌感染症治療薬の中南米市場規模2016-2027（メキシコ、ブラジル） ・グラム陰性菌感染症治療薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Baxter、Sanofi、GlaxoSmithKline、Novartis、Pfizer、Takeda、Nektar Therapeutics、Sumitomo、Targeted Genetics） ・結論

Gram-negative bacteria generally refer to bacteria that show red in the gram-negative staining reaction.

Market Analysis and Insights: Global Gram-Negative Bacterial Infection Therapeutics Market
The global Gram-Negative Bacterial Infection Therapeutics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Gram-Negative Bacterial Infection Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Gram-Negative Bacterial Infection Therapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Gram-Negative Bacterial Infection Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Gram-Negative Bacterial Infection Therapeutics market.

Global Gram-Negative Bacterial Infection Therapeutics Scope and Market Size
Gram-Negative Bacterial Infection Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Gram-Negative Bacterial Infection Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Enteral Treatment
Parenteral Treatment
Topical Treatment

Segment by Application
Hospitals
Clinics
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Baxter
Sanofi
GlaxoSmithKline
Novartis
Pfizer
Takeda
Nektar Therapeutics
Sumitomo
Targeted Genetics

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gram-Negative Bacterial Infection Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Enteral Treatment
1.2.3 Parenteral Treatment
1.2.4 Topical Treatment
1.3 Market by Application
1.3.1 Global Gram-Negative Bacterial Infection Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Gram-Negative Bacterial Infection Therapeutics Market Perspective (2016-2027)
2.2 Gram-Negative Bacterial Infection Therapeutics Growth Trends by Regions
2.2.1 Gram-Negative Bacterial Infection Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Gram-Negative Bacterial Infection Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Gram-Negative Bacterial Infection Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Gram-Negative Bacterial Infection Therapeutics Industry Dynamic
2.3.1 Gram-Negative Bacterial Infection Therapeutics Market Trends
2.3.2 Gram-Negative Bacterial Infection Therapeutics Market Drivers
2.3.3 Gram-Negative Bacterial Infection Therapeutics Market Challenges
2.3.4 Gram-Negative Bacterial Infection Therapeutics Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Gram-Negative Bacterial Infection Therapeutics Players by Revenue
3.1.1 Global Top Gram-Negative Bacterial Infection Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Gram-Negative Bacterial Infection Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Gram-Negative Bacterial Infection Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Gram-Negative Bacterial Infection Therapeutics Revenue
3.4 Global Gram-Negative Bacterial Infection Therapeutics Market Concentration Ratio
3.4.1 Global Gram-Negative Bacterial Infection Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gram-Negative Bacterial Infection Therapeutics Revenue in 2020
3.5 Gram-Negative Bacterial Infection Therapeutics Key Players Head office and Area Served
3.6 Key Players Gram-Negative Bacterial Infection Therapeutics Product Solution and Service
3.7 Date of Enter into Gram-Negative Bacterial Infection Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Gram-Negative Bacterial Infection Therapeutics Breakdown Data by Type
4.1 Global Gram-Negative Bacterial Infection Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Gram-Negative Bacterial Infection Therapeutics Forecasted Market Size by Type (2022-2027)

5 Gram-Negative Bacterial Infection Therapeutics Breakdown Data by Application
5.1 Global Gram-Negative Bacterial Infection Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Gram-Negative Bacterial Infection Therapeutics Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Gram-Negative Bacterial Infection Therapeutics Market Size (2016-2027)
6.2 North America Gram-Negative Bacterial Infection Therapeutics Market Size by Type
6.2.1 North America Gram-Negative Bacterial Infection Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Gram-Negative Bacterial Infection Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Gram-Negative Bacterial Infection Therapeutics Market Size by Type (2016-2027)
6.3 North America Gram-Negative Bacterial Infection Therapeutics Market Size by Application
6.3.1 North America Gram-Negative Bacterial Infection Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Gram-Negative Bacterial Infection Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Gram-Negative Bacterial Infection Therapeutics Market Size by Application (2016-2027)
6.4 North America Gram-Negative Bacterial Infection Therapeutics Market Size by Country
6.4.1 North America Gram-Negative Bacterial Infection Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Gram-Negative Bacterial Infection Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Gram-Negative Bacterial Infection Therapeutics Market Size (2016-2027)
7.2 Europe Gram-Negative Bacterial Infection Therapeutics Market Size by Type
7.2.1 Europe Gram-Negative Bacterial Infection Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Gram-Negative Bacterial Infection Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Gram-Negative Bacterial Infection Therapeutics Market Size by Type (2016-2027)
7.3 Europe Gram-Negative Bacterial Infection Therapeutics Market Size by Application
7.3.1 Europe Gram-Negative Bacterial Infection Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Gram-Negative Bacterial Infection Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Gram-Negative Bacterial Infection Therapeutics Market Size by Application (2016-2027)
7.4 Europe Gram-Negative Bacterial Infection Therapeutics Market Size by Country
7.4.1 Europe Gram-Negative Bacterial Infection Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Gram-Negative Bacterial Infection Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Gram-Negative Bacterial Infection Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Gram-Negative Bacterial Infection Therapeutics Market Size by Type
8.2.1 Asia-Pacific Gram-Negative Bacterial Infection Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Gram-Negative Bacterial Infection Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Gram-Negative Bacterial Infection Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Gram-Negative Bacterial Infection Therapeutics Market Size by Application
8.3.1 Asia-Pacific Gram-Negative Bacterial Infection Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Gram-Negative Bacterial Infection Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Gram-Negative Bacterial Infection Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Gram-Negative Bacterial Infection Therapeutics Market Size by Region
8.4.1 Asia-Pacific Gram-Negative Bacterial Infection Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Gram-Negative Bacterial Infection Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Gram-Negative Bacterial Infection Therapeutics Market Size (2016-2027)
9.2 Latin America Gram-Negative Bacterial Infection Therapeutics Market Size by Type
9.2.1 Latin America Gram-Negative Bacterial Infection Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Gram-Negative Bacterial Infection Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Gram-Negative Bacterial Infection Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Gram-Negative Bacterial Infection Therapeutics Market Size by Application
9.3.1 Latin America Gram-Negative Bacterial Infection Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Gram-Negative Bacterial Infection Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Gram-Negative Bacterial Infection Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Gram-Negative Bacterial Infection Therapeutics Market Size by Country
9.4.1 Latin America Gram-Negative Bacterial Infection Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Gram-Negative Bacterial Infection Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Gram-Negative Bacterial Infection Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Gram-Negative Bacterial Infection Therapeutics Market Size by Type
10.2.1 Middle East & Africa Gram-Negative Bacterial Infection Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Gram-Negative Bacterial Infection Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Gram-Negative Bacterial Infection Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Gram-Negative Bacterial Infection Therapeutics Market Size by Application
10.3.1 Middle East & Africa Gram-Negative Bacterial Infection Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Gram-Negative Bacterial Infection Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Gram-Negative Bacterial Infection Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Gram-Negative Bacterial Infection Therapeutics Market Size by Country
10.4.1 Middle East & Africa Gram-Negative Bacterial Infection Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Gram-Negative Bacterial Infection Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Baxter
11.1.1 Baxter Company Details
11.1.2 Baxter Business Overview
11.1.3 Baxter Gram-Negative Bacterial Infection Therapeutics Introduction
11.1.4 Baxter Revenue in Gram-Negative Bacterial Infection Therapeutics Business (2016-2021)
11.1.5 Baxter Recent Development
11.2 Sanofi
11.2.1 Sanofi Company Details
11.2.2 Sanofi Business Overview
11.2.3 Sanofi Gram-Negative Bacterial Infection Therapeutics Introduction
11.2.4 Sanofi Revenue in Gram-Negative Bacterial Infection Therapeutics Business (2016-2021)
11.2.5 Sanofi Recent Development
11.3 GlaxoSmithKline
11.3.1 GlaxoSmithKline Company Details
11.3.2 GlaxoSmithKline Business Overview
11.3.3 GlaxoSmithKline Gram-Negative Bacterial Infection Therapeutics Introduction
11.3.4 GlaxoSmithKline Revenue in Gram-Negative Bacterial Infection Therapeutics Business (2016-2021)
11.3.5 GlaxoSmithKline Recent Development
11.4 Novartis
11.4.1 Novartis Company Details
11.4.2 Novartis Business Overview
11.4.3 Novartis Gram-Negative Bacterial Infection Therapeutics Introduction
11.4.4 Novartis Revenue in Gram-Negative Bacterial Infection Therapeutics Business (2016-2021)
11.4.5 Novartis Recent Development
11.5 Pfizer
11.5.1 Pfizer Company Details
11.5.2 Pfizer Business Overview
11.5.3 Pfizer Gram-Negative Bacterial Infection Therapeutics Introduction
11.5.4 Pfizer Revenue in Gram-Negative Bacterial Infection Therapeutics Business (2016-2021)
11.5.5 Pfizer Recent Development
11.6 Takeda
11.6.1 Takeda Company Details
11.6.2 Takeda Business Overview
11.6.3 Takeda Gram-Negative Bacterial Infection Therapeutics Introduction
11.6.4 Takeda Revenue in Gram-Negative Bacterial Infection Therapeutics Business (2016-2021)
11.6.5 Takeda Recent Development
11.7 Nektar Therapeutics
11.7.1 Nektar Therapeutics Company Details
11.7.2 Nektar Therapeutics Business Overview
11.7.3 Nektar Therapeutics Gram-Negative Bacterial Infection Therapeutics Introduction
11.7.4 Nektar Therapeutics Revenue in Gram-Negative Bacterial Infection Therapeutics Business (2016-2021)
11.7.5 Nektar Therapeutics Recent Development
11.8 Sumitomo
11.8.1 Sumitomo Company Details
11.8.2 Sumitomo Business Overview
11.8.3 Sumitomo Gram-Negative Bacterial Infection Therapeutics Introduction
11.8.4 Sumitomo Revenue in Gram-Negative Bacterial Infection Therapeutics Business (2016-2021)
11.8.5 Sumitomo Recent Development
11.9 Targeted Genetics
11.9.1 Targeted Genetics Company Details
11.9.2 Targeted Genetics Business Overview
11.9.3 Targeted Genetics Gram-Negative Bacterial Infection Therapeutics Introduction
11.9.4 Targeted Genetics Revenue in Gram-Negative Bacterial Infection Therapeutics Business (2016-2021)
11.9.5 Targeted Genetics Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Gram-Negative Bacterial Infection Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Enteral Treatment
Table 3. Key Players of Parenteral Treatment
Table 4. Key Players of Topical Treatment
Table 5. Global Gram-Negative Bacterial Infection Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Gram-Negative Bacterial Infection Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Gram-Negative Bacterial Infection Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Gram-Negative Bacterial Infection Therapeutics Market Share by Regions (2016-2021)
Table 9. Global Gram-Negative Bacterial Infection Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Gram-Negative Bacterial Infection Therapeutics Market Share by Regions (2022-2027)
Table 11. Gram-Negative Bacterial Infection Therapeutics Market Trends
Table 12. Gram-Negative Bacterial Infection Therapeutics Market Drivers
Table 13. Gram-Negative Bacterial Infection Therapeutics Market Challenges
Table 14. Gram-Negative Bacterial Infection Therapeutics Market Restraints
Table 15. Global Gram-Negative Bacterial Infection Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Gram-Negative Bacterial Infection Therapeutics Market Share by Players (2016-2021)
Table 17. Global Top Gram-Negative Bacterial Infection Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gram-Negative Bacterial Infection Therapeutics as of 2020)
Table 18. Ranking of Global Top Gram-Negative Bacterial Infection Therapeutics Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Gram-Negative Bacterial Infection Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Gram-Negative Bacterial Infection Therapeutics Product Solution and Service
Table 22. Date of Enter into Gram-Negative Bacterial Infection Therapeutics Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Gram-Negative Bacterial Infection Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Gram-Negative Bacterial Infection Therapeutics Revenue Market Share by Type (2016-2021)
Table 26. Global Gram-Negative Bacterial Infection Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Gram-Negative Bacterial Infection Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Gram-Negative Bacterial Infection Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Gram-Negative Bacterial Infection Therapeutics Revenue Market Share by Application (2016-2021)
Table 30. Global Gram-Negative Bacterial Infection Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Gram-Negative Bacterial Infection Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Gram-Negative Bacterial Infection Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Gram-Negative Bacterial Infection Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Gram-Negative Bacterial Infection Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Gram-Negative Bacterial Infection Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Gram-Negative Bacterial Infection Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Gram-Negative Bacterial Infection Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Gram-Negative Bacterial Infection Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Gram-Negative Bacterial Infection Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Gram-Negative Bacterial Infection Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Gram-Negative Bacterial Infection Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Gram-Negative Bacterial Infection Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Gram-Negative Bacterial Infection Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Gram-Negative Bacterial Infection Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Gram-Negative Bacterial Infection Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Gram-Negative Bacterial Infection Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Gram-Negative Bacterial Infection Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Gram-Negative Bacterial Infection Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Gram-Negative Bacterial Infection Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Gram-Negative Bacterial Infection Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Gram-Negative Bacterial Infection Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Gram-Negative Bacterial Infection Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Gram-Negative Bacterial Infection Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Gram-Negative Bacterial Infection Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Gram-Negative Bacterial Infection Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Gram-Negative Bacterial Infection Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Gram-Negative Bacterial Infection Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Gram-Negative Bacterial Infection Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Gram-Negative Bacterial Infection Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Gram-Negative Bacterial Infection Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Gram-Negative Bacterial Infection Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 62. Baxter Company Details
Table 63. Baxter Business Overview
Table 64. Baxter Gram-Negative Bacterial Infection Therapeutics Product
Table 65. Baxter Revenue in Gram-Negative Bacterial Infection Therapeutics Business (2016-2021) & (US$ Million)
Table 66. Baxter Recent Development
Table 67. Sanofi Company Details
Table 68. Sanofi Business Overview
Table 69. Sanofi Gram-Negative Bacterial Infection Therapeutics Product
Table 70. Sanofi Revenue in Gram-Negative Bacterial Infection Therapeutics Business (2016-2021) & (US$ Million)
Table 71. Sanofi Recent Development
Table 72. GlaxoSmithKline Company Details
Table 73. GlaxoSmithKline Business Overview
Table 74. GlaxoSmithKline Gram-Negative Bacterial Infection Therapeutics Product
Table 75. GlaxoSmithKline Revenue in Gram-Negative Bacterial Infection Therapeutics Business (2016-2021) & (US$ Million)
Table 76. GlaxoSmithKline Recent Development
Table 77. Novartis Company Details
Table 78. Novartis Business Overview
Table 79. Novartis Gram-Negative Bacterial Infection Therapeutics Product
Table 80. Novartis Revenue in Gram-Negative Bacterial Infection Therapeutics Business (2016-2021) & (US$ Million)
Table 81. Novartis Recent Development
Table 82. Pfizer Company Details
Table 83. Pfizer Business Overview
Table 84. Pfizer Gram-Negative Bacterial Infection Therapeutics Product
Table 85. Pfizer Revenue in Gram-Negative Bacterial Infection Therapeutics Business (2016-2021) & (US$ Million)
Table 86. Pfizer Recent Development
Table 87. Takeda Company Details
Table 88. Takeda Business Overview
Table 89. Takeda Gram-Negative Bacterial Infection Therapeutics Product
Table 90. Takeda Revenue in Gram-Negative Bacterial Infection Therapeutics Business (2016-2021) & (US$ Million)
Table 91. Takeda Recent Development
Table 92. Nektar Therapeutics Company Details
Table 93. Nektar Therapeutics Business Overview
Table 94. Nektar Therapeutics Gram-Negative Bacterial Infection Therapeutics Product
Table 95. Nektar Therapeutics Revenue in Gram-Negative Bacterial Infection Therapeutics Business (2016-2021) & (US$ Million)
Table 96. Nektar Therapeutics Recent Development
Table 97. Sumitomo Company Details
Table 98. Sumitomo Business Overview
Table 99. Sumitomo Revenue in Gram-Negative Bacterial Infection Therapeutics Business (2016-2021) & (US$ Million)
Table 100. Sumitomo Recent Development
Table 101. Targeted Genetics Company Details
Table 102. Targeted Genetics Business Overview
Table 103. Targeted Genetics Gram-Negative Bacterial Infection Therapeutics Product
Table 104. Targeted Genetics Revenue in Gram-Negative Bacterial Infection Therapeutics Business (2016-2021) & (US$ Million)
Table 105. Targeted Genetics Recent Development
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Gram-Negative Bacterial Infection Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. Enteral Treatment Features
Figure 3. Parenteral Treatment Features
Figure 4. Topical Treatment Features
Figure 5. Global Gram-Negative Bacterial Infection Therapeutics Market Share by Application: 2020 VS 2027
Figure 6. Hospitals Case Studies
Figure 7. Clinics Case Studies
Figure 8. Others Case Studies
Figure 9. Gram-Negative Bacterial Infection Therapeutics Report Years Considered
Figure 10. Global Gram-Negative Bacterial Infection Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Gram-Negative Bacterial Infection Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Gram-Negative Bacterial Infection Therapeutics Market Share by Regions: 2020 VS 2027
Figure 13. Global Gram-Negative Bacterial Infection Therapeutics Market Share by Regions (2022-2027)
Figure 14. Global Gram-Negative Bacterial Infection Therapeutics Market Share by Players in 2020
Figure 15. Global Top Gram-Negative Bacterial Infection Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gram-Negative Bacterial Infection Therapeutics as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Gram-Negative Bacterial Infection Therapeutics Revenue in 2020
Figure 17. Global Gram-Negative Bacterial Infection Therapeutics Revenue Market Share by Type (2016-2021)
Figure 18. Global Gram-Negative Bacterial Infection Therapeutics Revenue Market Share by Type (2022-2027)
Figure 19. North America Gram-Negative Bacterial Infection Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Gram-Negative Bacterial Infection Therapeutics Market Share by Type (2016-2027)
Figure 21. North America Gram-Negative Bacterial Infection Therapeutics Market Share by Application (2016-2027)
Figure 22. North America Gram-Negative Bacterial Infection Therapeutics Market Share by Country (2016-2027)
Figure 23. United States Gram-Negative Bacterial Infection Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Gram-Negative Bacterial Infection Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Gram-Negative Bacterial Infection Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Gram-Negative Bacterial Infection Therapeutics Market Share by Type (2016-2027)
Figure 27. Europe Gram-Negative Bacterial Infection Therapeutics Market Share by Application (2016-2027)
Figure 28. Europe Gram-Negative Bacterial Infection Therapeutics Market Share by Country (2016-2027)
Figure 29. Germany Gram-Negative Bacterial Infection Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Gram-Negative Bacterial Infection Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Gram-Negative Bacterial Infection Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Gram-Negative Bacterial Infection Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Gram-Negative Bacterial Infection Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Gram-Negative Bacterial Infection Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Gram-Negative Bacterial Infection Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Gram-Negative Bacterial Infection Therapeutics Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Gram-Negative Bacterial Infection Therapeutics Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Gram-Negative Bacterial Infection Therapeutics Market Share by Region (2016-2027)
Figure 39. China Gram-Negative Bacterial Infection Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Gram-Negative Bacterial Infection Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Gram-Negative Bacterial Infection Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Gram-Negative Bacterial Infection Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Gram-Negative Bacterial Infection Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Gram-Negative Bacterial Infection Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Gram-Negative Bacterial Infection Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Gram-Negative Bacterial Infection Therapeutics Market Share by Type (2016-2027)
Figure 47. Latin America Gram-Negative Bacterial Infection Therapeutics Market Share by Application (2016-2027)
Figure 48. Latin America Gram-Negative Bacterial Infection Therapeutics Market Share by Country (2016-2027)
Figure 49. Mexico Gram-Negative Bacterial Infection Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Gram-Negative Bacterial Infection Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Gram-Negative Bacterial Infection Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Gram-Negative Bacterial Infection Therapeutics Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Gram-Negative Bacterial Infection Therapeutics Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Gram-Negative Bacterial Infection Therapeutics Market Share by Country (2016-2027)
Figure 55. Turkey Gram-Negative Bacterial Infection Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Gram-Negative Bacterial Infection Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Gram-Negative Bacterial Infection Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Baxter Revenue Growth Rate in Gram-Negative Bacterial Infection Therapeutics Business (2016-2021)
Figure 59. Sanofi Revenue Growth Rate in Gram-Negative Bacterial Infection Therapeutics Business (2016-2021)
Figure 60. GlaxoSmithKline Revenue Growth Rate in Gram-Negative Bacterial Infection Therapeutics Business (2016-2021)
Figure 61. Novartis Revenue Growth Rate in Gram-Negative Bacterial Infection Therapeutics Business (2016-2021)
Figure 62. Pfizer Revenue Growth Rate in Gram-Negative Bacterial Infection Therapeutics Business (2016-2021)
Figure 63. Takeda Revenue Growth Rate in Gram-Negative Bacterial Infection Therapeutics Business (2016-2021)
Figure 64. Nektar Therapeutics Revenue Growth Rate in Gram-Negative Bacterial Infection Therapeutics Business (2016-2021)
Figure 65. Sumitomo Revenue Growth Rate in Gram-Negative Bacterial Infection Therapeutics Business (2016-2021)
Figure 66. Targeted Genetics Revenue Growth Rate in Gram-Negative Bacterial Infection Therapeutics Business (2016-2021)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed

---